| Projections of cancer incidence and cancer‐related deaths in Germany by 2020 and 2030 AS Quante, C Ming, M Rottmann, J Engel, S Boeck, V Heinemann, ... Cancer medicine 5 (9), 2649-2656, 2016 | 305 | 2016 |
| Expansion of the genotypic and phenotypic spectrum in patients with KRAS germline mutations M Zenker, K Lehmann, AL Schulz, H Barth, D Hansmann, R Koenig, ... Journal of medical genetics 44 (2), 131-135, 2007 | 228 | 2007 |
| Effects of metformin on metabolite profiles and LDL cholesterol in patients with type 2 diabetes T Xu, S Brandmaier, AC Messias, C Herder, HHM Draisma, A Demirkan, ... Diabetes care 38 (10), 1858-1867, 2015 | 153 | 2015 |
| Breast cancer risk assessment across the risk continuum: genetic and nongenetic risk factors contributing to differential model performance AS Quante, AS Whittemore, T Shriver, K Strauch, MB Terry Breast Cancer Research 14, 1-12, 2012 | 145 | 2012 |
| High-risk breast cancer surveillance with MRI: 10-year experience from the German consortium for hereditary breast and ovarian cancer U Bick, C Engel, B Krug, W Heindel, EM Fallenberg, K Rhiem, D Maintz, ... Breast cancer research and treatment 175, 217-228, 2019 | 128 | 2019 |
| Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification MT Parsons, E Tudini, H Li, E Hahnen, B Wappenschmidt, L Feliubadaló, ... Human mutation 40 (9), 1557-1578, 2019 | 124 | 2019 |
| Perceived risk of diabetes seriously underestimates actual diabetes risk: The KORA FF4 study B Kowall, W Rathmann, A Stang, B Bongaerts, O Kuss, C Herder, ... PloS one 12 (1), e0171152, 2017 | 98 | 2017 |
| Changes in mammographic density over time in breast cancer cases and women at high risk for breast cancer ME Work, LL Reimers, AS Quante, KD Crew, A Whiffen, MB Terry International journal of cancer 135 (7), 1740-1744, 2014 | 56 | 2014 |
| Practical problems with clinical guidelines for breast cancer prevention based on remaining lifetime risk AS Quante, AS Whittemore, T Shriver, JL Hopper, K Strauch, MB Terry Journal of the National Cancer Institute 107 (7), djv124, 2015 | 46 | 2015 |
| Breast cancer risk in BRCA1/2 mutation carriers and noncarriers under prospective intensified surveillance C Engel, C Fischer, S Zachariae, K Bucksch, K Rhiem, J Giesecke, ... International journal of cancer 146 (4), 999-1009, 2020 | 40 | 2020 |
| Performance of Breast Cancer Polygenic Risk Scores in 760 Female CHEK2 Germline Mutation Carriers J Borde, C Ernst, B Wappenschmidt, D Niederacher, K Weber-Lassalle, ... JNCI: Journal of the National Cancer Institute 113 (7), 893-899, 2021 | 35 | 2021 |
| Goblet cell ratio in combination with differentiation and stem cell markers in Barrett esophagus allow distinction of patients with and without esophageal adenocarcinoma R Schellnegger, A Quante, S Rospleszcz, M Schernhammer, B Höhl, ... Cancer Prevention Research 10 (1), 55-66, 2017 | 29 | 2017 |
| Toward targeted prevention: risk factors for prediabetes defined by impaired fasting glucose, impaired glucose tolerance and increased HbA1c in the population-based KORA study … GG Greiner, KMF Emmert-Fees, J Becker, W Rathmann, B Thorand, ... Acta diabetologica 57, 1481-1491, 2020 | 25 | 2020 |
| Genome-wide association study identifies susceptibility loci for acute myeloid leukemia WY Lin, SE Fordham, E Hungate, NJ Sunter, C Elstob, Y Xu, C Park, ... Nature Communications 12 (1), 6233, 2021 | 24 | 2021 |
| German Consortium for Hereditary Breast and Ovarian Cancer (GC-HBOC). High-risk breast cancer surveillance with MRI: 10-year experience from the German consortium for … U Bick, C Engel, B Krug, W Heindel, EM Fallenberg, K Rhiem, D Maintz, ... Breast Cancer Res Treat 175 (1), 217-28, 2019 | 21 | 2019 |
| BarrettNET—a prospective registry for risk estimation of patients with Barrett's esophagus to progress to adenocarcinoma M Wiethaler, J Slotta-Huspenina, A Brandtner, J Horstmann, F Wein, ... Diseases of the Esophagus 32 (8), doz024, 2019 | 15 | 2019 |
| The association between serum 25-hydroxyvitamin D and cancer risk: results from the prospective KORA F4 study CP Cheney, B Thorand, C Huth, K Berger, A Peters, V Seifert-Klauss, ... Oncology Research and Treatment 41 (3), 117-121, 2018 | 15 | 2018 |
| Differential associations between diet and prediabetes or diabetes in the KORA FF4 study TA Breuninger, A Riedl, N Wawro, W Rathmann, K Strauch, A Quante, ... Journal of nutritional science 7, e34, 2018 | 15 | 2018 |
| Modifying effect of metabotype on diet–diabetes associations A Riedl, N Wawro, C Gieger, C Meisinger, A Peters, W Rathmann, ... European journal of nutrition 59, 1357-1369, 2020 | 14 | 2020 |
| Umstrukturierung der Risikoberechnung für die intensivierte Früherkennung im Deutschen Konsortium für Brust-und Eierstockkrebs AS Quante, C Engel, M Kiechle, RK Schmutzler, C Fischer Die Gynäkologie 53 (4), 259-264, 2020 | 14 | 2020 |
